The same disrupting strategy targeting the D2R and the dopamine transporter (DAT) restored locomotor activity in control and dopamine-depleted rats by increasing the extracellular dopamine, and exerted beneficial effects in a rat model of attention-deficit hyperactivity disorder [40]. This evidence concerns the gene SLC6A3 and attention deficit-hyperactivity disorder.